Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection: A Case Report
https://doi.org/10.4081/ejtm.2021.9494
Accepted: 8 May 2021
HTML: 4
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
A 56-year-old man was referred to the emergency department for the subacute onset of and weakness in the lower extremities, paraesthesia and pain. He was diagnosed with SARS-CoV-2 pneumonia and then, he received the necessary treatment according to national protocol. Radiographic, laboratory, and electroneurographic findings indicated an acute polyradiculoneuritis with prominent demyelination and suggesting the diagnosis of Guillain-Barr syndrome associated with COVID-19 infection.
Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020 Apr 1;130(4):1545-1548. DOI: https://doi.org/10.1172/JCI138003
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061-1069. Erratum in: JAMA. 2021 Mar 16;325(11):1113. DOI: https://doi.org/10.1001/jama.2020.1585
Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020 Jun;92(6):552-555. Epub 2020 Mar 11. DOI: https://doi.org/10.1002/jmv.25728
Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, Viganò M, Giovannelli G, Pirro F, Montisano DA, Appollonio I, Ferrarese C. Guillain-Barré syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm. 2020 Apr 29;7(4):e741. DOI: https://doi.org/10.1212/NXI.0000000000000741
Karimi N, Sedaghat Z. Letter to the editor. Concerning the article entitled ''Guillain Barre syndrome associated with COVID-19 infection: A case report". J Clin Neurosci. 2020 Sep;79:257-258. Epub 2020 Jul 4. DOI: https://doi.org/10.1016/j.jocn.2020.06.025
Jacobs BC, Rothbarth PH, van der Meché FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998 Oct;51(4):1110-5. DOI: https://doi.org/10.1212/WNL.51.4.1110
Mcgrath TM. Infections of the Central Nervous System, 4th edn. Chap 20. Guillain-Barré Syndrome. Accessed via https://doctorlib. info/ infectiology/infections-central-nervous-system/21.html.
Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, Eddins DL, Bryan JA. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. Am J Epidemiol. 1979 Aug;110(2):105-23. DOI: https://doi.org/10.1093/oxfordjournals.aje.a112795
Brison E, Jacomy H, Desforges M, Talbot PJ. Glutamate excitotoxicity is involved in the induction of paralysis in mice after infection by a human coronavirus with a single point mutation in its spike protein. J Virol. 2011 Dec;85(23):12464-73. Epub 2011 Sep 28. DOI: https://doi.org/10.1128/JVI.05576-11
Zhao K, Huang J, Dai D, Feng Y, Liu L, Nie S. Acute myelitis after SARS-CoV-2 infection: a case report. medRxiv preprint. Mar 2020. https://doi.org/10.1101/2020.03.16.20035105. DOI: https://doi.org/10.1101/2020.03.16.20035105
Ashrafi MR, Azizimalamiri R, Shervin Badv R, Tavasoli AR, Nikkhah A, Montazerlotfelahi H, et al. Coronavirus, Its Neurologic Manifestations, and Complications. Iran J Pediatr. 2020 April; 30(2):e102569. DOI: https://doi.org/10.5812/ijp.102569
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
